Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss CHRS - Coherus BioSciences, Inc.
-248 K
LAST VALUE
4.16%
2 YEAR CAGR
2.54%
5 YEAR CAGR
8.83%
10 YEAR CAGR